Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients
Status:
Recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind controlled Study from a single center to evaluate the effect and
safety of pramipexole on peritoneal dialysis patients with restless legs syndrome